Total Payments
$8,685
2024 Payments
$1,111
Companies
43
Transactions
456
Medicare Patients
1,737
Medicare Billing
$132,073
Payment Breakdown by Category
Food & Beverage$8,503 (97.9%)
Research$126.02 (1.5%)
Education$56.48 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,503 | 448 | 97.9% |
| Unspecified | $126.02 | 1 | 1.5% |
| Education | $56.48 | 7 | 0.7% |
Payments by Type
General
$8,559
455 transactions
Research
$126.02
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $1,296 | 60 | $0 (2024) |
| Abbott Laboratories | $1,058 | 46 | $0 (2024) |
| Novo Nordisk Inc | $1,000 | 69 | $0 (2024) |
| ABBVIE INC. | $723.73 | 52 | $0 (2024) |
| Amgen Inc. | $469.43 | 23 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $454.15 | 22 | $0 (2024) |
| Medtronic MiniMed, Inc. | $408.23 | 13 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $332.43 | 19 | $0 (2021) |
| Xeris Pharmaceuticals, Inc. | $276.59 | 15 | $0 (2024) |
| Medtronic, Inc. | $255.28 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,111 | 57 | Chiesi USA, Inc. ($168.00) |
| 2023 | $909.70 | 50 | Abbott Laboratories ($156.77) |
| 2022 | $1,729 | 63 | Abbott Laboratories ($425.18) |
| 2021 | $1,211 | 59 | Lilly USA, LLC ($307.31) |
| 2020 | $1,021 | 53 | Lilly USA, LLC ($250.21) |
| 2019 | $802.99 | 38 | Medtronic MiniMed, Inc. ($308.80) |
| 2018 | $601.17 | 53 | Novo Nordisk Inc ($180.04) |
| 2017 | $1,300 | 83 | Novo Nordisk Inc ($397.33) |
All Payment Transactions
456 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $10.20 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/04/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: Diabetes Care | ||||||
| 12/03/2024 | PFIZER INC. | SOMAVERT (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
| 11/23/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Endocrinology | ||||||
| 11/21/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $32.85 | General |
| Category: Endocrinology | ||||||
| 11/21/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $2.52 | General |
| Category: Endocrinology | ||||||
| 11/12/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $27.35 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/12/2024 | Amgen Inc. | TEPEZZA (Biological) | Education | In-kind items and services | $10.02 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/11/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $33.69 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/31/2024 | Chiesi USA, Inc. | MYCAPSSA (Drug) | Food and Beverage | Cash or cash equivalent | $23.99 | General |
| Category: ACROMEGALY | ||||||
| 10/30/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $9.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/29/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: Diabetes Care | ||||||
| 10/17/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Durable Pump | ||||||
| 10/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/01/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $31.82 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/27/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 09/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $36.41 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $9.64 | General |
| Category: Bone Health | ||||||
| 09/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $18.48 | General |
| Category: Insulin Pump | ||||||
| 08/15/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Durable Pump | ||||||
| 08/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/01/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $10.72 | General |
| Category: Bone Health | ||||||
| 07/22/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $17.61 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| CORT125134-456 [GRADIENT] | Corcept Therapeutics | $126.02 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 337 | 606 | $48,315 | $27,591 |
| 2022 | 5 | 397 | 817 | $56,840 | $32,360 |
| 2021 | 6 | 474 | 979 | $65,971 | $39,969 |
| 2020 | 6 | 529 | 1,014 | $56,033 | $32,153 |
Total Patients
1,737
Total Services
3,416
Medicare Billing
$132,073
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 184 | 381 | $37,918 | $22,073 | 58.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $5,684 | $3,246 | 57.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 29 | $4,093 | $1,707 | 41.7% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 49 | 75 | $336.75 | $288.75 | 85.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 53 | 94 | $282.00 | $276.36 | 98.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 199 | 451 | $44,460 | $25,289 | 56.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 47 | $6,512 | $3,612 | 55.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $4,804 | $2,477 | 51.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 75 | 169 | $507.00 | $501.27 | 98.9% |
| 82947 | Blood glucose (sugar) level | Office | 2022 | 65 | 124 | $556.76 | $480.56 | 86.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 214 | 485 | $48,251 | $28,877 | 59.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 47 | 65 | $9,265 | $5,146 | 55.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 37 | 37 | $6,755 | $4,443 | 65.8% |
| 82947 | Blood glucose (sugar) level | Office | 2021 | 80 | 171 | $767.79 | $672.03 | 87.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 85 | 196 | $588.00 | $588.00 | 100.0% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 11 | 25 | $344.50 | $242.75 | 70.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 221 | 465 | $38,367 | $21,189 | 55.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 52 | 81 | $10,144 | $6,108 | 60.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 29 | 29 | $5,525 | $3,129 | 56.6% |
| 82947 | Blood glucose (sugar) level | Office | 2020 | 103 | 196 | $880.04 | $764.36 | 86.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 104 | 207 | $621.00 | $616.38 | 99.3% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 20 | 36 | $496.08 | $346.90 | 69.9% |
About Dr. Jaime Castro, M.D
Dr. Jaime Castro, M.D is a Specialist healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932159951.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jaime Castro, M.D has received a total of $8,685 in payments from pharmaceutical and medical device companies, with $1,111 received in 2024. These payments were reported across 456 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($8,503).
As a Medicare-enrolled provider, Castro has provided services to 1,737 Medicare beneficiaries, totaling 3,416 services with total Medicare billing of $132,073. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Fort Worth, TX
- Active Since 05/11/2006
- Last Updated 06/24/2019
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1932159951
Products in Payments
- FREESTYLE LIBRE (Device) $716.13
- Ozempic (Drug) $382.93
- TRULICITY (Drug) $334.90
- Minimed 670G System (Device) $324.17
- FreeStyle Libre (Device) $312.69
- FARXIGA (Drug) $310.24
- JARDIANCE (Drug) $255.77
- Repatha (Biological) $237.81
- SYNTHROID (Drug) $209.94
- GVOKE PFS (Drug) $196.41
- BAQSIMI (Drug) $192.06
- MOUNJARO (Drug) $180.54
- MYCAPSSA (Drug) $168.00
- SOLIQUA 100/33 (Biological) $160.05
- SOMAVERT (Drug) $159.80
- Tresiba (Drug) $151.31
- Synthroid (Drug) $150.04
- Victoza (Drug) $145.37
- LYUMJEV (Drug) $139.28
- Omnipod (Device) $134.70
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Fort Worth
Jay Roberts, D.o, D.O
Specialist — Payments: $119,796
Specialist $119,796
Richard Vigness, M. D, M. D
Specialist — Payments: $90,363
Specialist $90,363
Dr. Louis Strock, M.d, M.D
Specialist — Payments: $71,191
Specialist $71,191
Dr. Adam Smith, D.o, D.O
Specialist — Payments: $38,927
Specialist $38,927
Charles Secrest, Md, MD
Specialist — Payments: $28,015
Specialist $28,015
Steven Singleton, M.d, M.D
Specialist — Payments: $24,056
Specialist $24,056